Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Kaltsas

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Clinical Endocrinology|August 16, 2003
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptorBlerina Kola, Márta Korbonits, Salvador Diaz-Cano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2022
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasmsIvan Borbath, Rocio Garcia-Carbonero, Damir Bikmukhametov, et al.
Neuroendocrinology|May 11, 2010
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumorsMarianne Pavel, Ashley Grossman, Rudolf Arnold, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2015
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential HypertensionAthina Markou, Amalia Sertedaki, Gregory Kaltsas, et al.
Anticancer Research|January 2, 2010
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006John Griniatsos, Chris Tsigris, Meletios Kanakis, et al.
Clinical Endocrinology|June 14, 2016
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretionAmalia Sertedaki, Athina Markou, Dimitrios Vlachakis, et al.
Neuroendocrinology|March 3, 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine TumorsGregory Kaltsas, Martyn Caplin, Philippa Davies, et al.
Endocrine|January 13, 2019
The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practiceKrystallenia I Alexandraki, Michail Pizanias, Inbal Uri, et al.
International Journal of Molecular Sciences|January 20, 2021
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE<sup>(-/-)</sup> Mice by Activating Autophagy and Reducing ER Stress and ApoptosisNarjes Nasiri-Ansari, Chrysa Nikolopoulou, Katerina Papoutsi, et al.
Journal of Neuroendocrinology|February 14, 2022
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)John K Ramage, Elizabeth Friend, Jordan Randell, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Clinical Endocrinology|August 16, 2003
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptorBlerina Kola, Márta Korbonits, Salvador Diaz-Cano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2022
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasmsIvan Borbath, Rocio Garcia-Carbonero, Damir Bikmukhametov, et al.
Neuroendocrinology|May 11, 2010
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumorsMarianne Pavel, Ashley Grossman, Rudolf Arnold, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2015
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential HypertensionAthina Markou, Amalia Sertedaki, Gregory Kaltsas, et al.
Anticancer Research|January 2, 2010
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006John Griniatsos, Chris Tsigris, Meletios Kanakis, et al.
Clinical Endocrinology|June 14, 2016
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretionAmalia Sertedaki, Athina Markou, Dimitrios Vlachakis, et al.
Neuroendocrinology|March 3, 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine TumorsGregory Kaltsas, Martyn Caplin, Philippa Davies, et al.
Endocrine|January 13, 2019
The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practiceKrystallenia I Alexandraki, Michail Pizanias, Inbal Uri, et al.
International Journal of Molecular Sciences|January 20, 2021
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE<sup>(-/-)</sup> Mice by Activating Autophagy and Reducing ER Stress and ApoptosisNarjes Nasiri-Ansari, Chrysa Nikolopoulou, Katerina Papoutsi, et al.
Journal of Neuroendocrinology|February 14, 2022
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)John K Ramage, Elizabeth Friend, Jordan Randell, et al.
Pageof 23